ALHEMO
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ALHEMO, covering 2024-12-20 to 2025-09-25. Get the full timeline:
Most recent: EMA Authorised: Alhemo (concizumab) — Novo Nordisk A/S
6 regulatory and trial events tracked for ALHEMO, covering 2024-12-20 to 2025-09-25. Get the full timeline:
Most recent: EMA Authorised: Alhemo (concizumab) — Novo Nordisk A/S